Placenta
Volume 31, Issue 4 , Pages 344-346 , April 2010

Analysis of Placental Tissue in Fabry Disease With and Without Enzyme Replacement Therapy

  • M.G. Bouwman

      Affiliations

    • Department of Paediatrics, Emma Children's Hospital, Amsterdam, The Netherlands
    • ,
  • C.E.M. Hollak

      Affiliations

    • Department of Internal Medicine, Division of Endocrinology and Metabolism, Amsterdam, The Netherlands
    • ,
  • M.A. van den Bergh Weerman

      Affiliations

    • Department of Pathology, All at the Academic Medical Center, Amsterdam, The Netherlands
    • ,
  • F.A. Wijburg

      Affiliations

    • Department of Paediatrics, Emma Children's Hospital, Amsterdam, The Netherlands
    • ,
  • G.E. Linthorst

      Affiliations

    • Department of Internal Medicine, Division of Endocrinology and Metabolism, Amsterdam, The Netherlands
    • Corresponding Author InformationCorresponding author. Department of Internal Medicine (F5-166), Division of Endocrinology and Metabolism, Academic Medical Center, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands. Tel.: +31 205668890.

,Accepted 3 February 2010.

References 

  1. Desnick RJ, Ioannou YA, Eng ME. α-Galactosidase A deficiency: Fabry disease. In:  Scriver CR,  Beaudet AL,  Sly WS,  Valle D editor. The metabolic and molecular bases of inherited disease. New York: McGraw-Hill; 2001;p. 3733–3774
  2. Vedder AC, Strijland A, vd Bergh Weerman MA, Florquin S, Aerts JMFG, Hollak CEM. Manifestations of Fabry disease in placental tissue. J Inherit Metab Dis. 2006;29:106–111
  3. Elleder M, Poupetova H, Kozich V. [Fetal pathology in Fabry's disease and mucopolysaccharidosis type 1], Cesk Patol. 1998;34:7–12
  4. Popli S, Leehey DJ, Molnar ZV, Nawab ZM, Ing TS. Demonstration of Fabry's disease deposits in placenta. Am J Obstet Gynecol. 1990;162:464–465

PII: S0143-4004(10)00057-3

doi: 10.1016/j.placenta.2010.02.004

Placenta
Volume 31, Issue 4 , Pages 344-346 , April 2010

Article Tools

* Image Usage & Resolution